{"title":"A 20-Year Retrospective of Kidney Cancer Journal: 2003-2022","authors":"S. Pazhanisamy","doi":"10.52733/kcj20n1-20yr","DOIUrl":null,"url":null,"abstract":"These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.","PeriodicalId":74040,"journal":{"name":"Kidney cancer journal : official journal of the Kidney Cancer Association","volume":"629 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer journal : official journal of the Kidney Cancer Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52733/kcj20n1-20yr","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
